Arginine, citrulline and nitric oxide metabolism in sepsis

Christina C. Kao, Venkata Bandi, Kalpalatha K. Guntupalli, Manhong Wu, Leticia Castillo, Farook Jahoor

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Arginine has vasodilatory effects, via its conversion by NO synthase into NO, and immunomodulatory actions which play important roles in sepsis. Protein breakdown affects arginine availability and the release of asymmetric dimethylarginine, an inhibitor of NO synthase, may therefore affect NO synthesis in patients with sepsis. The objective of the present study was to investigate whole-body in vivo arginine and citrulline metabolism and NO synthesis rates, and their relationship to protein breakdown in patients with sepsis or septic shock and in healthy volunteers. Endogenous leucine flux, an index of whole-body protein breakdown rate, was measured in 13 critically ill patients with sepsis or septic shock and seven healthy controls using an intravenous infusion of [1-13C]leucine. Arginine flux, citrulline flux and the rate of conversion of arginine into citrulline (an index of NO synthesis) were measured with intravenous infusions of [15N2]guanidino-arginine and [5,5-2H2]citrulline. Plasma concentrations of nitrite plus nitrate, arginine, citrulline and asymmetric dimethylarginine were measured. Compared with controls, patients had a higher leucine flux and higher NO metabolites, but arginine flux, plasma asymmetric dimethylarginine concentration and the rate of NO synthesis were not different. Citrulline flux and plasma arginine and citrulline were lower in patients than in controls. Arginine production was positively correlated with the protein breakdown rate. Whole-body arginine production and NO synthesis were similar in patients with sepsis and septic shock and healthy controls. Despite increased proteolysis in sepsis, there is a decreased arginine plasma concentration, suggesting inadequate de novo synthesis secondary to decreased citrulline production.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalClinical Science
Volume117
Issue number1
DOIs
StatePublished - Aug 3 2009
Externally publishedYes

Fingerprint

Citrulline
Arginine
Sepsis
Nitric Oxide
Septic Shock
Leucine
Intravenous Infusions
Nitric Oxide Synthase
Proteins
Nitrites
Critical Illness
Nitrates
Proteolysis
Healthy Volunteers

Keywords

  • Arginine
  • Citrulline
  • Isotope
  • Nitric oxide
  • Septic shock

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kao, C. C., Bandi, V., Guntupalli, K. K., Wu, M., Castillo, L., & Jahoor, F. (2009). Arginine, citrulline and nitric oxide metabolism in sepsis. Clinical Science, 117(1), 23-30. https://doi.org/10.1042/CS20080444

Arginine, citrulline and nitric oxide metabolism in sepsis. / Kao, Christina C.; Bandi, Venkata; Guntupalli, Kalpalatha K.; Wu, Manhong; Castillo, Leticia; Jahoor, Farook.

In: Clinical Science, Vol. 117, No. 1, 03.08.2009, p. 23-30.

Research output: Contribution to journalArticle

Kao, CC, Bandi, V, Guntupalli, KK, Wu, M, Castillo, L & Jahoor, F 2009, 'Arginine, citrulline and nitric oxide metabolism in sepsis', Clinical Science, vol. 117, no. 1, pp. 23-30. https://doi.org/10.1042/CS20080444
Kao, Christina C. ; Bandi, Venkata ; Guntupalli, Kalpalatha K. ; Wu, Manhong ; Castillo, Leticia ; Jahoor, Farook. / Arginine, citrulline and nitric oxide metabolism in sepsis. In: Clinical Science. 2009 ; Vol. 117, No. 1. pp. 23-30.
@article{0f602fe8f4e14323a7622ad98c4a1193,
title = "Arginine, citrulline and nitric oxide metabolism in sepsis",
abstract = "Arginine has vasodilatory effects, via its conversion by NO synthase into NO, and immunomodulatory actions which play important roles in sepsis. Protein breakdown affects arginine availability and the release of asymmetric dimethylarginine, an inhibitor of NO synthase, may therefore affect NO synthesis in patients with sepsis. The objective of the present study was to investigate whole-body in vivo arginine and citrulline metabolism and NO synthesis rates, and their relationship to protein breakdown in patients with sepsis or septic shock and in healthy volunteers. Endogenous leucine flux, an index of whole-body protein breakdown rate, was measured in 13 critically ill patients with sepsis or septic shock and seven healthy controls using an intravenous infusion of [1-13C]leucine. Arginine flux, citrulline flux and the rate of conversion of arginine into citrulline (an index of NO synthesis) were measured with intravenous infusions of [15N2]guanidino-arginine and [5,5-2H2]citrulline. Plasma concentrations of nitrite plus nitrate, arginine, citrulline and asymmetric dimethylarginine were measured. Compared with controls, patients had a higher leucine flux and higher NO metabolites, but arginine flux, plasma asymmetric dimethylarginine concentration and the rate of NO synthesis were not different. Citrulline flux and plasma arginine and citrulline were lower in patients than in controls. Arginine production was positively correlated with the protein breakdown rate. Whole-body arginine production and NO synthesis were similar in patients with sepsis and septic shock and healthy controls. Despite increased proteolysis in sepsis, there is a decreased arginine plasma concentration, suggesting inadequate de novo synthesis secondary to decreased citrulline production.",
keywords = "Arginine, Citrulline, Isotope, Nitric oxide, Septic shock",
author = "Kao, {Christina C.} and Venkata Bandi and Guntupalli, {Kalpalatha K.} and Manhong Wu and Leticia Castillo and Farook Jahoor",
year = "2009",
month = "8",
day = "3",
doi = "10.1042/CS20080444",
language = "English (US)",
volume = "117",
pages = "23--30",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "1",

}

TY - JOUR

T1 - Arginine, citrulline and nitric oxide metabolism in sepsis

AU - Kao, Christina C.

AU - Bandi, Venkata

AU - Guntupalli, Kalpalatha K.

AU - Wu, Manhong

AU - Castillo, Leticia

AU - Jahoor, Farook

PY - 2009/8/3

Y1 - 2009/8/3

N2 - Arginine has vasodilatory effects, via its conversion by NO synthase into NO, and immunomodulatory actions which play important roles in sepsis. Protein breakdown affects arginine availability and the release of asymmetric dimethylarginine, an inhibitor of NO synthase, may therefore affect NO synthesis in patients with sepsis. The objective of the present study was to investigate whole-body in vivo arginine and citrulline metabolism and NO synthesis rates, and their relationship to protein breakdown in patients with sepsis or septic shock and in healthy volunteers. Endogenous leucine flux, an index of whole-body protein breakdown rate, was measured in 13 critically ill patients with sepsis or septic shock and seven healthy controls using an intravenous infusion of [1-13C]leucine. Arginine flux, citrulline flux and the rate of conversion of arginine into citrulline (an index of NO synthesis) were measured with intravenous infusions of [15N2]guanidino-arginine and [5,5-2H2]citrulline. Plasma concentrations of nitrite plus nitrate, arginine, citrulline and asymmetric dimethylarginine were measured. Compared with controls, patients had a higher leucine flux and higher NO metabolites, but arginine flux, plasma asymmetric dimethylarginine concentration and the rate of NO synthesis were not different. Citrulline flux and plasma arginine and citrulline were lower in patients than in controls. Arginine production was positively correlated with the protein breakdown rate. Whole-body arginine production and NO synthesis were similar in patients with sepsis and septic shock and healthy controls. Despite increased proteolysis in sepsis, there is a decreased arginine plasma concentration, suggesting inadequate de novo synthesis secondary to decreased citrulline production.

AB - Arginine has vasodilatory effects, via its conversion by NO synthase into NO, and immunomodulatory actions which play important roles in sepsis. Protein breakdown affects arginine availability and the release of asymmetric dimethylarginine, an inhibitor of NO synthase, may therefore affect NO synthesis in patients with sepsis. The objective of the present study was to investigate whole-body in vivo arginine and citrulline metabolism and NO synthesis rates, and their relationship to protein breakdown in patients with sepsis or septic shock and in healthy volunteers. Endogenous leucine flux, an index of whole-body protein breakdown rate, was measured in 13 critically ill patients with sepsis or septic shock and seven healthy controls using an intravenous infusion of [1-13C]leucine. Arginine flux, citrulline flux and the rate of conversion of arginine into citrulline (an index of NO synthesis) were measured with intravenous infusions of [15N2]guanidino-arginine and [5,5-2H2]citrulline. Plasma concentrations of nitrite plus nitrate, arginine, citrulline and asymmetric dimethylarginine were measured. Compared with controls, patients had a higher leucine flux and higher NO metabolites, but arginine flux, plasma asymmetric dimethylarginine concentration and the rate of NO synthesis were not different. Citrulline flux and plasma arginine and citrulline were lower in patients than in controls. Arginine production was positively correlated with the protein breakdown rate. Whole-body arginine production and NO synthesis were similar in patients with sepsis and septic shock and healthy controls. Despite increased proteolysis in sepsis, there is a decreased arginine plasma concentration, suggesting inadequate de novo synthesis secondary to decreased citrulline production.

KW - Arginine

KW - Citrulline

KW - Isotope

KW - Nitric oxide

KW - Septic shock

UR - http://www.scopus.com/inward/record.url?scp=67749091272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749091272&partnerID=8YFLogxK

U2 - 10.1042/CS20080444

DO - 10.1042/CS20080444

M3 - Article

VL - 117

SP - 23

EP - 30

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 1

ER -